期刊文献+

大肠癌端粒酶各组分表达及其与端粒酶活性的关系

THE RELATION BETWWEEN THE THREE COMPONENTS ANDTHE ACTIVITY OF TELOMERASE IN COLORECTAL CANCER
下载PDF
导出
摘要 目的 :研究端粒酶的 3种组分与其活性的关系 ,探讨端粒酶激活的关键因素。方法 :采用 TRAP法检测大肠癌组织及相邻正常黏膜组织中端粒酶活性 ,用 RT-PCR检测端粒酶 3种组分的表达。结果 :在 6 4例 ( 85 .33% )癌组织中检测到端粒酶活性 ,正常黏膜中没有端粒酶活性 ,两者差异有显著性 ( P <0 .0 1) ;h TR和 TP1基因的表达在癌组织和正常黏膜没有差别 ,而 h TERT在癌组织中的表达要明显高于正常黏膜 ,差别具有显著性 ( P <0 .0 1) ,h TERT基因表达强度与端粒酶活性密切相关。结论 :大肠癌端粒酶活性表达具有肿瘤特异性 ,h TERT在癌组织中的表达明显高于正常粘膜 ,大肠癌中端粒酶活性和 h TERT基因表达强度密切相关 ,h Objective: To investigate the relation between the three components and the activity of telomerase and to find out which component is the rate limiting determinant of the enzymatic activity Methods: Using the telomerase repeat accelerate protocol (TRAP) to detect the telomerase activity and using the RT PCR to detect the expression of the three components of telomerase Results: More than 85% colorectal cancer tissues have telomerase activity whereas normal colon mucosa haven't hTR and TP1 mPNA were commonly expressed in cancer tissues and normal mucosa However the expression of hTERT in Cancer tissues are much higher than in the normal tissues The difference is significant There is strong correlation between telomerase activity and hTERT expression Conclusion: Telomerase has a special expression in colorectal cancer The expression of hTERT is higher in cancer tissues than in the normal tissues The expression of hTERT may be the rate limiting determinant of the enzymatic activity
出处 《大肠肛门病外科杂志》 2001年第4期6-9,共4页 Journal of Coloproctological Surgery
基金 国家自然科学基金资助 (基金编 3 9870 84 0 )
关键词 端粒酶 组分 HTERT基因 大肠癌 telomerase components hTERT gene
  • 相关文献

参考文献1

二级参考文献12

  • 1[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J] .Science, 1994; 266:2011-2015 被引量:1
  • 2[2]Rhyu M. Telormerase, telomerase, immortality [J]. J Natl Cancer Inst, 1995, 87:885-894 被引量:1
  • 3[3]Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996, 17:116-122 被引量:1
  • 4[4]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer [J]. EurJ Cancer, 1997,33:787-791 被引量:1
  • 5[5]Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomeraser activity levels with human neuroblastoma outcomes [J ]. Nature Med, 1995, ( 1 ): 249-255 被引量:1
  • 6[6]Engelhardt M, Drullinsky P, Guillem J. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer [J]. Clin Cancer Res, 1997, 3:1931-1941 被引量:1
  • 7[7]Engelhardt M, Albanell J, Drullinsky P, et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma [J] . Clin Cancer Res, 1997,3:1849-1857 被引量:1
  • 8[8]Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995, 55:3258-3262 被引量:1
  • 9[9]Blasco M, Rizen M, Greider C, et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis [J]. Nature Genet, 1996,12:200-204 被引量:1
  • 10[10]Avilion A, Piayszek A, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues [J ].Cancer Res, 1996,56:645-650 被引量:1

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部